TY - JOUR
T1 - Global prevalence of urolithiasis
T2 - a meta-analysis accounting for methodological heterogeneity
AU - Vera-Ponce, Víctor Juan
AU - Sanchez-Tamay, Nataly Mayely
AU - Ballena-Caicedo, Jhosmer
AU - Zuzunaga-Montoya, Fiorella E.
AU - De Carrillo, Carmen Inés Gutierrez
AU - Poemape Mestanza, Rossmery Leonor
N1 - Publisher Copyright:
Copyright © 2025 Vera-Ponce, Sanchez-Tamay, Ballena-Caicedo, Zuzunaga-Montoya, De Carrillo and Poemape Mestanza.
PY - 2025
Y1 - 2025
N2 - Introduction: Urolithiasis, also known as renal lithiasis or nephrolithiasis, is an increasingly relevant urological pathology worldwide. Objective: To estimate the global prevalence of urolithiasis through a systematic review (SR) with meta-analysis, and to systematically investigate methodological sources of heterogeneity in reported prevalence, including differences according to diagnostic methods, sex, and geographical regions. Methodology: A SR followed PRISMA guidelines adapted for prevalence studies, searching SCOPUS, Web of Science, PubMed, and EMBASE. Observational studies were included in reporting the frequency of urolithiasis diagnosed by ultrasound, tomography, or self-report. A meta-analysis of proportions was performed using a random-effects model with double arcsine transformation. Subgroup analyses by diagnostic method, sex, sampling strategy, and geographical region were conducted. Additionally, meta-regression was conducted to analyze the influence of publication year on prevalence. Results: In the combined analysis of 22 studies encompassing 1, 276, 826 participants, the estimated global prevalence of urolithiasis was 10.85% (95% CI: 8.76–13.14%). Considerable heterogeneity was observed (I² = 100%). Subgroup analyses revealed that diagnostic methods substantially influenced estimates: ultrasound 8.71% (95% CI: 5.74–12.23%), computed tomography 7.83% (95% CI: 7.12–8.60%), and self-report 13.28% (95% CI: 9.98–16.98%). Probabilistic sampling yielded 8.59% (95% CI: 6.34–11.14%) versus non-probabilistic 12.24% (95% CI: 9.32–15.50%). Prevalence was higher in males (12.93%) than females (8.91%). Regional variation ranged from 22.3% (Africa) to 8.3% (North America). Meta-regression showed publication year had no significant effect when adjusted for methodological factors (p = 0.1304). Conclusions: Urolithiasis affects approximately 11% of the global population, constituting a public health problem requiring comprehensive preventive, diagnostic, and therapeutic actions. The substantial heterogeneity is largely explained by methodological factors, particularly diagnostic methods and sampling strategies. This highlights the critical importance of standardizing diagnostic and recruitment criteria to obtain comparable measurements for guiding health policies and future research.
AB - Introduction: Urolithiasis, also known as renal lithiasis or nephrolithiasis, is an increasingly relevant urological pathology worldwide. Objective: To estimate the global prevalence of urolithiasis through a systematic review (SR) with meta-analysis, and to systematically investigate methodological sources of heterogeneity in reported prevalence, including differences according to diagnostic methods, sex, and geographical regions. Methodology: A SR followed PRISMA guidelines adapted for prevalence studies, searching SCOPUS, Web of Science, PubMed, and EMBASE. Observational studies were included in reporting the frequency of urolithiasis diagnosed by ultrasound, tomography, or self-report. A meta-analysis of proportions was performed using a random-effects model with double arcsine transformation. Subgroup analyses by diagnostic method, sex, sampling strategy, and geographical region were conducted. Additionally, meta-regression was conducted to analyze the influence of publication year on prevalence. Results: In the combined analysis of 22 studies encompassing 1, 276, 826 participants, the estimated global prevalence of urolithiasis was 10.85% (95% CI: 8.76–13.14%). Considerable heterogeneity was observed (I² = 100%). Subgroup analyses revealed that diagnostic methods substantially influenced estimates: ultrasound 8.71% (95% CI: 5.74–12.23%), computed tomography 7.83% (95% CI: 7.12–8.60%), and self-report 13.28% (95% CI: 9.98–16.98%). Probabilistic sampling yielded 8.59% (95% CI: 6.34–11.14%) versus non-probabilistic 12.24% (95% CI: 9.32–15.50%). Prevalence was higher in males (12.93%) than females (8.91%). Regional variation ranged from 22.3% (Africa) to 8.3% (North America). Meta-regression showed publication year had no significant effect when adjusted for methodological factors (p = 0.1304). Conclusions: Urolithiasis affects approximately 11% of the global population, constituting a public health problem requiring comprehensive preventive, diagnostic, and therapeutic actions. The substantial heterogeneity is largely explained by methodological factors, particularly diagnostic methods and sampling strategies. This highlights the critical importance of standardizing diagnostic and recruitment criteria to obtain comparable measurements for guiding health policies and future research.
KW - kidney calculi
KW - meta-analysis
KW - nephrolithiasis
KW - prevalence
KW - systematic review
UR - https://www.scopus.com/pages/publications/105026828059
U2 - 10.3389/fruro.2025.1705953
DO - 10.3389/fruro.2025.1705953
M3 - Review article
AN - SCOPUS:105026828059
SN - 2673-9828
VL - 5
JO - Frontiers in Urology
JF - Frontiers in Urology
M1 - 1705953
ER -